Add to ORKGhigh-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer a template for drug discovery in any cancer type
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
Exome sequencing reveals a potential mutational trajectory and treatments for a specific pancreatic ...
Most cancer drugs are not specific enough, causing unwanted side effects and recurrence of treated t...
of a screen to identify selective small molecules active against patient-derived metastatic and chem...
Influence networks based on coexpression improve drug target discovery for the development of novel ...
Identifying cancer mutation targets across thousands of samples: MuteProc, a high throughput mutatio...
BackgroundThere is an urgent need for better therapeutics in head and neck squamous cell cancer (HNS...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
in identifying genes mediating sensitivity to chemotherapeutic drugs: statistical approaches and per...
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency s...
Despite advances in therapeutic options for head and neck cancer (HNC), treatment-associated toxicit...
BACKGROUND: There is an urgent need for better therapeutics in head and neck squamous cell cancer (H...
Copyright: © Fox et al. This is an open-access article distributed under the terms of the Creative ...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
Exome sequencing reveals a potential mutational trajectory and treatments for a specific pancreatic ...
Most cancer drugs are not specific enough, causing unwanted side effects and recurrence of treated t...
of a screen to identify selective small molecules active against patient-derived metastatic and chem...
Influence networks based on coexpression improve drug target discovery for the development of novel ...
Identifying cancer mutation targets across thousands of samples: MuteProc, a high throughput mutatio...
BackgroundThere is an urgent need for better therapeutics in head and neck squamous cell cancer (HNS...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
in identifying genes mediating sensitivity to chemotherapeutic drugs: statistical approaches and per...
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency s...
Despite advances in therapeutic options for head and neck cancer (HNC), treatment-associated toxicit...
BACKGROUND: There is an urgent need for better therapeutics in head and neck squamous cell cancer (H...
Copyright: © Fox et al. This is an open-access article distributed under the terms of the Creative ...
1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
Exome sequencing reveals a potential mutational trajectory and treatments for a specific pancreatic ...
Most cancer drugs are not specific enough, causing unwanted side effects and recurrence of treated t...